Nuclear uptake control of NF-kappa B by MAD-3, an I kappa B protein present in the nucleus
about
Regulation of IkappaBalpha function and NF-kappaB signaling: AEBP1 is a novel proinflammatory mediator in macrophagesGREB1 functions as a growth promoter and is modulated by IL6/STAT3 in breast cancerBCL3 encodes a nuclear protein which can alter the subcellular location of NF-kappa B proteinsI kappa B alpha-mediated inhibition of v-Rel DNA binding requires direct interaction with the RXXRXRXXC Rel/kappa B DNA-binding motifStimulation of ionotropic glutamate receptors activates transcription factor NF-kappa B in primary neuronsA proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa BPurification, reconstitution, and I kappa B association of the c-Rel-p65 (RelA) complex, a strong activator of transcriptionRole of unphosphorylated, newly synthesized I kappa B beta in persistent activation of NF-kappa BCytoskeletal control of gene expression: depolymerization of microtubules activates NF-kappa BControl of NF-kappa B transcriptional activation by signal induced proteolysis of I kappa B alphaAngiotensin II induced inflammation in the kidney and in the heart of double transgenic ratsCautionary notes on the use of NF-κB p65 and p50 antibodies for CNS studiesStructural Basis of HIV-1 Activation by NF-κB—A Higher-Order Complex of p50:RelA Bound to the HIV-1 LTRTranscription Factors in the Cellular Response to Charged Particle ExposureKBF1 (p50 NF-kappa B homodimer) acts as a repressor of H-2Kb gene expression in metastatic tumor cellsRegulation of serum amyloid A protein expression during the acute-phase responseContribution of TNF-alpha and nuclear factor-kappaB signaling to type 2 iodothyronine deiodinase activation in the mediobasal hypothalamus after lipopolysaccharide administrationConstitutive NF-kappa B activity in neuronsPhosphorylation of I kappa B alpha precedes but is not sufficient for its dissociation from NF-kappa BDNA binding alters the protease susceptibility of the p50 subunit of NF-kappa B.Mechanisms directing the nuclear localization of the CtBP family proteins.Activation of nuclear factor kappa B (NF-kappaB) assayed by laser scanning cytometry (LSC)Mechanisms and signals for the nuclear import of proteinsDistinct domains of IkappaBalpha regulate c-Rel in the cytoplasm and in the nucleus.Loss of IkappaB alpha-mediated control over nuclear import and DNA binding enables oncogenic activation of c-RelNuclear localization of IkappaB alpha is mediated by the second ankyrin repeat: the IkappaB alpha ankyrin repeats define a novel class of cis-acting nuclear import sequences.Alternative splicing variants of IkappaB beta establish differential NF-kappaB signal responsiveness in human cells.The mastermind-like 1 (MAML1) co-activator regulates constitutive NF-kappaB signaling and cell survivalDissection of a novel nuclear localization signal in open reading frame 29 of varicella-zoster virus.The oncoprotein Bcl-3 can facilitate NF-kappa B-mediated transactivation by removing inhibiting p50 homodimers from select kappa B sites.In vivo control of NF-kappa B activation by I kappa B alpha.Interleukin-10 inhibits the in vivo and in vitro adverse effects of TNF-alpha on the endothelium of murine aorta.Development of a sensitive multi-well colorimetric assay for active NFkappaBA novel signal transduction pathway from the endoplasmic reticulum to the nucleus is mediated by transcription factor NF-kappa B.Transcriptional regulation of hTREX84 in human cancer cells.Regulation of IkappaBbeta expression in testis.An adeno-associated virus-based intracellular sensor of pathological nuclear factor-κB activation for disease-inducible gene transfer.Activation of adult rat CNS endothelial cells by opioid-induced toll-like receptor 4 (TLR4) signaling induces proinflammatory, biochemical, morphological, and behavioral sequelaeProteolytic degradation of MAD3 (I kappa B alpha) and enhanced processing of the NF-kappa B precursor p105 are obligatory steps in the activation of NF-kappa B.Ligand-induced differentiation of glucocorticoid receptor (GR) trans-repression and transactivation: preferential targetting of NF-kappaB and lack of I-kappaB involvement.
P2860
Q21296830-570BB423-8450-4B94-962D-A44208FB3512Q21560759-7B2F1135-DEA8-47F3-BD59-BDB9EDFB6833Q24315909-A82A86AE-041A-4F06-BAEE-9146DFC89A25Q24561403-A777745D-8A16-4A31-853C-02D52F163874Q24563145-9C6403EC-238D-4C47-BC77-35AD49DD3DB7Q24568234-CDE829E7-BDC3-406B-96F8-95BCC08D88F5Q24613327-D05C0994-D0C9-4443-BE50-D0930E5C6BB2Q24648375-AF61CD98-C6CD-4254-8D94-93797F96226FQ24672676-602FE881-D777-473D-B5CA-29B9007B6D10Q24676497-B395F03D-3598-4E24-8D40-3867468E7216Q24800784-6B9119B9-3CF4-4E34-9140-826E1BF216FEQ27497868-65E3EB87-B248-473D-9605-0C17C1881A41Q27657031-A61F0448-D2B3-4468-B8AF-71C0F7E55DEEQ28069717-17490847-E75C-4EEA-BF10-52972354FBA1Q28269339-86ECBC8B-E73B-4D9C-B1BE-5977FC3DEC61Q28281545-FB49B2B2-E680-4CC6-B958-739F73DC16BAQ28580420-DF9FBDD6-8867-454C-8795-6909AC8A685AQ28582881-B4EF7AEE-8658-4130-BBE6-75CF7B509E93Q28615823-DD01E47D-B3CB-4014-9FDF-5F23DDF87ADBQ30421431-5082A9D6-2691-49DC-B2B0-F2BA48D74F96Q30445758-96345DFC-05C8-4A56-A781-DAB7E480D33DQ31971734-AF8FCB44-FC5D-453F-B2DE-0DE9DCEEBDA3Q33635365-24FE3A24-B79C-4152-B153-FEE5E49369E4Q33771931-4E4DCDF1-1826-4C82-B4E7-A1F00A0F96C2Q33778864-57168FBF-CD7C-42C1-9457-A7603C2A1307Q33786457-EBF93ACD-D9A5-4E02-9257-A14C12186050Q33786480-99B9EE3B-AC23-47F7-9B78-7B22CD0A3DEEQ33825084-787DABFC-8725-4A3A-B898-CA24084D7870Q34045683-ABDDFB80-28BF-4A6A-85BB-D5367F30A72BQ34061332-6A19062C-FC15-478D-970A-79CBD9BF1AE0Q34069959-1C3736C0-DA13-44AE-BBD3-DE3CB6A80890Q34212252-05774481-C295-4582-9BB4-3E170953AB35Q34233830-0A305747-42C5-42E8-B0AB-2C7337EBF8E3Q34313045-2FC4875B-66EC-4BD7-98FB-378786DF5CFFQ34405377-E5E62A40-CD9E-412D-98FC-9C3698730957Q34416813-8106F808-16A7-43D8-AD26-7E433C0FA948Q34542364-BAB9A15B-5476-4224-B483-563FCA8B1E4AQ34603199-24C1DE75-37F3-455B-9860-64474903C123Q35019615-65DC1659-C60C-46F1-9A32-E4FC8EC73D63Q35029015-51991A0B-F166-4655-A327-313751804473
P2860
Nuclear uptake control of NF-kappa B by MAD-3, an I kappa B protein present in the nucleus
description
1993 nî lūn-bûn
@nan
1993 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Nuclear uptake control of NF-k ...... protein present in the nucleus
@ast
Nuclear uptake control of NF-k ...... protein present in the nucleus
@en
Nuclear uptake control of NF-k ...... protein present in the nucleus
@en-gb
Nuclear uptake control of NF-k ...... protein present in the nucleus
@nl
type
label
Nuclear uptake control of NF-k ...... protein present in the nucleus
@ast
Nuclear uptake control of NF-k ...... protein present in the nucleus
@en
Nuclear uptake control of NF-k ...... protein present in the nucleus
@en-gb
Nuclear uptake control of NF-k ...... protein present in the nucleus
@nl
prefLabel
Nuclear uptake control of NF-k ...... protein present in the nucleus
@ast
Nuclear uptake control of NF-k ...... protein present in the nucleus
@en
Nuclear uptake control of NF-k ...... protein present in the nucleus
@en-gb
Nuclear uptake control of NF-k ...... protein present in the nucleus
@nl
P2093
P2860
P3181
P1433
P1476
Nuclear uptake control of NF-k ...... protein present in the nucleus
@en
P2093
P2860
P304
P3181
P356
10.1002/J.1460-2075.1993.TB05646.X
P407
P577
1993-01-01T00:00:00Z